C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to hsp90

被引:74
|
作者
Cheung-Flynn, J [1 ]
Roberts, PJ [1 ]
Riggs, DL [1 ]
Smith, DF [1 ]
机构
[1] Mayo Clin Scottsdale, Dept Biochem & Mol Biol, SC Johnson Res Ctr, Scottsdale, AZ 85259 USA
关键词
D O I
10.1074/jbc.M300955200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hsp90 assembles with steroid receptors and other client proteins in association with one or more Hsp90-binding cochaperones, some of which contain a common tetratricopeptide repeat (TPR) domain. Included in the TPR cochaperones are the Hsp70-Hsp90-organizing protein Hop, the FK506-binding immunophilins FKBP52 and FKBP51, the cyclosporin A-binding immunophilin CyP40, and protein phosphatase PP5. The TPR domains from these proteins have similar x-ray crystallographic structures and target cochaperone binding to the MEEVD sequence that terminates Hsp90. However, despite these similarities, the TPR cochaperones have distinctive properties for binding Hsp90 and assembling with Hsp90.steroid receptor complexes. To identify structural features that differentiate binding of FKBP51 and FKBP52 to Hsp90, we generated an assortment of truncation mutants and chimeras that were compared for coimmunoprecipitation with Hsp90. Although the core TPR domain (approximately amino acids 260-400) of FKBP51 and FKBP52 is required for Hsp90 binding, the C-terminal 60 amino acids (similar to400-end) also influence Hsp90 binding. More specifically, we find that amino acids 400-420 play a critical role for Hsp90 binding by either FKBP. Within this 20-amino acid region, we have identified a consensus sequence motif that is also present in some other TPR cochaperones. Additionally, the final 30 amino acids of FKBP51 enhance binding to Hsp90, whereas the corresponding region of FKBP52 moderates binding to Hsp90. Taking into account the x-ray crystal structure for FKBP51, we conclude that the C-terminal regions of FKBP51 and FKBP52 outside the core TPR domains are likely to assume alternative conformations that significantly impact Hsp90 binding.
引用
收藏
页码:17388 / 17394
页数:7
相关论文
共 24 条
  • [21] In silico identification and analysis of the binding site for aminocoumarin type inhibitors in the C-terminal domain of Hsp90
    Roy, Samir S.
    Kapoor, Manju
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 84 : 215 - 235
  • [22] A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90 -: N-terminal nucleotide binding unmasks a C-terminal binding pocket
    Söti, C
    Rácz, A
    Csermely, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) : 7066 - 7075
  • [23] Structural models and binding site prediction of the C-terminal domain of human hsp90: A new target for anticancer drugs
    Sgobba, Miriam
    Degliesposti, Gianluca
    Ferrari, Anna Maria
    Rastelli, Giulio
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (05) : 420 - 433
  • [24] Penicisulfuranol A, a novel C-terminal inhibitor disrupting molecular chaperone function of Hsp90 independent of ATP binding domain
    Dai, Jiajia
    Chen, Ao
    Zhu, Meilin
    Qi, Xin
    Tang, Wei
    Liu, Ming
    Li, Dehai
    Gu, Qianqun
    Li, Jing
    BIOCHEMICAL PHARMACOLOGY, 2019, 163 : 404 - 415